CIK: 0001615982 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $1,570,243 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $334,212 | 21.3% | $22.03 | +120.3% | COM | 03770N101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,026,331 | $94,095 | 6.0% | $18.38 | +14.5% | COM | 29337E102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,400,000 | $92,356 | 5.9% | $19.48 | +28.8% | COM | 35104E100 |
| OCUL | OCULAR THERAPEUTIX INC | 12,762,462 | $87,295 | 5.6% | $4.57 | +34.9% | COM | 67576A100 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $76,717 | 4.9% | $11.80 | +146.3% | COM | 26818M108 |
| — | MERUS N V | 1,263,214 | $74,744 | 4.8% | $20.36 | — | COM | N5749R100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,249,731 | $73,622 | 4.7% | $8.81 | +32.4% | COM | 483497103 |
| PHVS | PHARVARIS N V | 3,395,606 | $63,837 | 4.1% | $15.96 | +27.5% | COM | N69605108 |
| SYRE | SPYRE THERAPEUTICS INC | 2,685,448 | $63,135 | 4.0% | $17.59 | +91.7% | COM NEW | 00773J202 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,094,373 | $54,202 | 3.5% | $17.70 | +35.8% | COM | 252828108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,671 | $50,514 | 3.2% | $19.32 | -28.3% | COM | 92790C104 |
| COGT | COGENT BIOSCIENCES INC | 5,684,167 | $47,918 | 3.1% | $8.47 | -10.4% | COM | 19240Q201 |
| — | APPLIED THERAPEUTICS INC | 9,542,871 | $44,565 | 2.8% | $3.21 | — | COM | 03828A101 |
| ERAS | ERASCA INC | 16,216,216 | $38,270 | 2.4% | $2.16 | 0.0% | COM | 29479A108 |
| — | ASTRIA THERAPEUTICS INC | 3,608,645 | $32,839 | 2.1% | $8.36 | — | COM | 04635X102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,818,182 | $32,745 | 2.1% | $15.89 | +9.7% | COM | 28036F105 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,394,527 | $31,069 | 2.0% | $8.55 | +4.7% | COM | 68622P109 |
| PRAX | PRAXIS PRECISION MEDICINES I | 706,131 | $29,206 | 1.9% | $31.41 | +50.4% | COM NEW | 74006W207 |
| ENGN | ENGENE HOLDINGS INC | 2,825,983 | $26,649 | 1.7% | $12.29 | +4.4% | COM | 29286M105 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $24,067 | 1.5% | $21.29 | 0.0% | COM | 230031106 |
| TERN | TERNS PHARMACEUTICALS INC | 3,410,058 | $23,222 | 1.5% | $4.28 | +41.7% | COM | 880881107 |
| — | MERSANA THERAPEUTICS INC | 11,328,000 | $22,769 | 1.5% | $1.27 | — | COM | 59045L106 |
| ZURA | ZURA BIO LTD | 6,023,166 | $21,081 | 1.3% | $4.08 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| TSHA | TAYSHA GENE THERAPIES INC | 9,000,000 | $20,160 | 1.3% | $1.87 | +55.8% | COM SHS | 877619106 |
| ABVX | ABIVAX SA | 1,345,780 | $17,791 | 1.1% | $11.63 | — | SPONSORED ADS | 00370M103 |
| ARVN | ARVINAS INC | 627,788 | $16,712 | 1.1% | $23.38 | +36.3% | COM | 04335A105 |
| AQST | AQUESTIVE THERAPEUTICS INC | 5,555,555 | $14,444 | 0.9% | $3.33 | +0.3% | COM | 03843E104 |
| IPSC | CENTURY THERAPEUTICS INC | 5,389,259 | $13,743 | 0.9% | $3.84 | -17.6% | COM | 15673T100 |
| CABA | CABALETTA BIO INC | 1,563,952 | $11,698 | 0.7% | $6.85 | +79.0% | COM | 12674W109 |
| TRVI | TREVI THERAPEUTICS INC | 3,422,637 | $10,199 | 0.6% | $2.46 | +12.8% | COM | 89532M101 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,467,048 | $10,064 | 0.6% | $14.14 | — | COM NEW | 00773U207 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7,545 | 0.5% | $10.07 | 0.0% | CL A ORD SHS | G70077105 |
| TNYA | TENAYA THERAPEUTICS INC | 1,555,556 | $4,822 | 0.3% | $4.78 | -13.7% | COM | 87990A106 |
| — | ARCA BIOPHARMA INC | 866,375 | $3,318 | 0.2% | $3.83 | — | COM | 00211Y506 |
| CASIF | CASI PHARMACEUTICALS INC | 111,686 | $614 | 0.0% | $3.11 | 0.0% | ORD SHS | G1933S101 |